Influence ofSLCO1B1Polymorphisms on the Drug-Drug Interaction Between Darunavir/Ritonavir and Pravastatin-Reference-Cited by-同舟云学术

Influence ofSLCO1B1Polymorphisms on the Drug-Drug Interaction Between Darunavir/Ritonavir and Pravastatin

Published:2012-11 Issue:11 Volume:52 Page:1725-1738
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Aquilante Christina L.,Kiser Jennifer J.,Anderson Peter L.,Christians Uwe,Kosmiski Lisa A.,Daily Elizabeth B.,Hoffman Keith L.,Hopley Charles W.,Predhomme Julie A.,Schniedewind Bjorn,Sidhom Maha S.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference77 articles.

1. Recognition and management of significant drug interactions in HIV patients: challenges in using available data to guide therapy;Pau;Clin Pharmacol Ther,2010

2. Ritonavir: clinical pharmacokinetics and interactions with other anti-HIV agents;Hsu;Clin Pharmacokinet,1998

3. Pharmacokinetic enhancement of protease inhibitor therapy;King;Clin Pharmacokinet,2004

4. Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection;Fichtenbaum;Clin Pharmacokinet,2002

5. Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047;Fichtenbaum;AIDS,2002

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A biological pharmacology network to secure the risk of drug–drug interaction with nirmatrelvir/ritonavir;Therapies;2024-07

2. Drug–Drug Interactions and Drug–Dietary Chemical Interactions;Oral Bioavailability and Drug Delivery;2023-10-10

3. Pharmacokinetic Drug-Drug Interactions Involving Antiretroviral Agents: An Update;Current Drug Metabolism;2023-07

4. Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor‐containing regimen;British Journal of Clinical Pharmacology;2023-05-12

5. Erratum to: Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America;Clinical Infectious Diseases;2021-12-08